| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thoracic Outlet Syndrome | 27 | 2016 | 31 | 10.010 |
Why?
|
| General Surgery | 37 | 2018 | 81 | 9.990 |
Why?
|
| Ribs | 16 | 2015 | 40 | 5.730 |
Why?
|
| Vascular Surgical Procedures | 23 | 2018 | 91 | 4.280 |
Why?
|
| Aortic Aneurysm, Abdominal | 22 | 2019 | 47 | 3.950 |
Why?
|
| Decompression, Surgical | 10 | 2016 | 53 | 3.680 |
Why?
|
| Subclavian Vein | 10 | 2016 | 15 | 3.400 |
Why?
|
| Internship and Residency | 12 | 2018 | 283 | 3.130 |
Why?
|
| Burnout, Professional | 9 | 2018 | 44 | 2.990 |
Why?
|
| Physicians, Women | 12 | 2018 | 16 | 2.540 |
Why?
|
| Humans | 163 | 2019 | 29013 | 2.530 |
Why?
|
| Treatment Outcome | 56 | 2019 | 3099 | 2.350 |
Why?
|
| Osteotomy | 6 | 2015 | 48 | 2.340 |
Why?
|
| Periodicals as Topic | 10 | 2014 | 95 | 2.080 |
Why?
|
| Female | 99 | 2019 | 18114 | 2.040 |
Why?
|
| Postoperative Complications | 21 | 2019 | 670 | 1.980 |
Why?
|
| Job Satisfaction | 9 | 2019 | 37 | 1.940 |
Why?
|
| Workload | 8 | 2014 | 38 | 1.870 |
Why?
|
| Male | 97 | 2018 | 17768 | 1.870 |
Why?
|
| Academic Medical Centers | 8 | 2017 | 150 | 1.860 |
Why?
|
| Upper Extremity Deep Vein Thrombosis | 4 | 2014 | 7 | 1.770 |
Why?
|
| Patient Care Team | 7 | 2017 | 124 | 1.720 |
Why?
|
| United States | 57 | 2018 | 3604 | 1.700 |
Why?
|
| Retrospective Studies | 38 | 2017 | 3107 | 1.690 |
Why?
|
| Neck Muscles | 4 | 2014 | 8 | 1.680 |
Why?
|
| Surgical Procedures, Operative | 10 | 2013 | 74 | 1.650 |
Why?
|
| Leadership | 7 | 2018 | 34 | 1.630 |
Why?
|
| Ultrasonography, Doppler, Duplex | 8 | 2016 | 45 | 1.630 |
Why?
|
| Publishing | 9 | 2014 | 57 | 1.610 |
Why?
|
| Adult | 46 | 2017 | 8391 | 1.520 |
Why?
|
| Physicians | 7 | 2015 | 134 | 1.510 |
Why?
|
| Specialties, Surgical | 6 | 2018 | 24 | 1.450 |
Why?
|
| Stents | 11 | 2014 | 171 | 1.430 |
Why?
|
| Middle Aged | 46 | 2017 | 10805 | 1.340 |
Why?
|
| Clinical Competence | 4 | 2017 | 307 | 1.310 |
Why?
|
| Blood Vessel Prosthesis Implantation | 11 | 2015 | 68 | 1.240 |
Why?
|
| Quality of Life | 13 | 2016 | 815 | 1.230 |
Why?
|
| Societies, Medical | 9 | 2018 | 149 | 1.210 |
Why?
|
| Hospital Mortality | 6 | 2015 | 186 | 1.150 |
Why?
|
| Baltimore | 14 | 2015 | 49 | 1.150 |
Why?
|
| Arterial Occlusive Diseases | 3 | 2016 | 30 | 1.120 |
Why?
|
| Anticoagulants | 6 | 2014 | 120 | 1.110 |
Why?
|
| Young Adult | 17 | 2016 | 2398 | 1.100 |
Why?
|
| Vascular Patency | 10 | 2013 | 66 | 1.100 |
Why?
|
| Vascular Diseases | 2 | 2017 | 61 | 1.060 |
Why?
|
| Risk Factors | 32 | 2015 | 3509 | 1.050 |
Why?
|
| Education, Medical, Graduate | 5 | 2014 | 116 | 1.050 |
Why?
|
| Cervical Rib | 3 | 2013 | 4 | 1.040 |
Why?
|
| Aged | 47 | 2019 | 9462 | 1.030 |
Why?
|
| Time Factors | 28 | 2017 | 1997 | 1.020 |
Why?
|
| Femoral Artery | 7 | 2014 | 44 | 0.990 |
Why?
|
| Adolescent | 16 | 2016 | 3248 | 0.980 |
Why?
|
| Endarterectomy, Carotid | 11 | 2014 | 29 | 0.970 |
Why?
|
| Follow-Up Studies | 19 | 2019 | 2106 | 0.970 |
Why?
|
| Subclavian Artery | 3 | 2016 | 6 | 0.970 |
Why?
|
| Phlebography | 6 | 2014 | 26 | 0.950 |
Why?
|
| Faculty, Medical | 5 | 2017 | 69 | 0.930 |
Why?
|
| Hospital Administration | 3 | 2018 | 12 | 0.900 |
Why?
|
| Medical Errors | 5 | 2010 | 36 | 0.900 |
Why?
|
| Mentors | 6 | 2017 | 29 | 0.890 |
Why?
|
| Arteriovenous Shunt, Surgical | 5 | 2015 | 45 | 0.880 |
Why?
|
| Carotid Stenosis | 7 | 2014 | 56 | 0.880 |
Why?
|
| Career Mobility | 6 | 2018 | 14 | 0.870 |
Why?
|
| Social Class | 4 | 2015 | 71 | 0.870 |
Why?
|
| Physician-Patient Relations | 4 | 2015 | 169 | 0.850 |
Why?
|
| Decision Making | 5 | 2015 | 180 | 0.840 |
Why?
|
| Risk Assessment | 12 | 2015 | 1300 | 0.830 |
Why?
|
| Angioplasty, Balloon | 4 | 2014 | 33 | 0.820 |
Why?
|
| Intermittent Claudication | 4 | 2015 | 9 | 0.810 |
Why?
|
| Algorithms | 5 | 2011 | 461 | 0.810 |
Why?
|
| Hospitals, Teaching | 3 | 2010 | 28 | 0.800 |
Why?
|
| Cervical Rib Syndrome | 2 | 2013 | 3 | 0.750 |
Why?
|
| Thrombolytic Therapy | 3 | 2011 | 59 | 0.740 |
Why?
|
| Aneurysm | 4 | 2013 | 21 | 0.730 |
Why?
|
| Patient Selection | 6 | 2014 | 257 | 0.710 |
Why?
|
| Retirement | 1 | 2019 | 11 | 0.700 |
Why?
|
| Sexual Harassment | 2 | 2018 | 3 | 0.680 |
Why?
|
| Thrombosis | 3 | 2014 | 60 | 0.680 |
Why?
|
| Women, Working | 3 | 2017 | 12 | 0.670 |
Why?
|
| Mothers | 1 | 2019 | 79 | 0.670 |
Why?
|
| Organizational Policy | 1 | 2018 | 20 | 0.650 |
Why?
|
| Physician's Role | 2 | 2018 | 38 | 0.650 |
Why?
|
| Physical Therapy Modalities | 3 | 2014 | 60 | 0.640 |
Why?
|
| Quality of Health Care | 3 | 2017 | 134 | 0.640 |
Why?
|
| Neuromuscular Agents | 3 | 2015 | 28 | 0.640 |
Why?
|
| Attitude of Health Personnel | 8 | 2017 | 161 | 0.630 |
Why?
|
| Venous Thrombosis | 3 | 2013 | 48 | 0.610 |
Why?
|
| Stroke | 7 | 2014 | 522 | 0.610 |
Why?
|
| Continental Population Groups | 3 | 2015 | 221 | 0.600 |
Why?
|
| Evidence-Based Medicine | 3 | 2016 | 207 | 0.600 |
Why?
|
| Qualitative Research | 1 | 2017 | 142 | 0.600 |
Why?
|
| Career Choice | 7 | 2017 | 40 | 0.580 |
Why?
|
| Recurrence | 7 | 2014 | 235 | 0.580 |
Why?
|
| Registries | 5 | 2018 | 278 | 0.570 |
Why?
|
| Renal Dialysis | 3 | 2015 | 259 | 0.570 |
Why?
|
| Hospitals, Urban | 3 | 2011 | 12 | 0.570 |
Why?
|
| Length of Stay | 10 | 2016 | 291 | 0.560 |
Why?
|
| Healthcare Disparities | 6 | 2015 | 153 | 0.560 |
Why?
|
| School Admission Criteria | 1 | 2016 | 11 | 0.560 |
Why?
|
| Resilience, Psychological | 1 | 2016 | 15 | 0.560 |
Why?
|
| Lidocaine | 2 | 2015 | 17 | 0.560 |
Why?
|
| Aortic Diseases | 3 | 2011 | 54 | 0.550 |
Why?
|
| Names | 5 | 2012 | 7 | 0.550 |
Why?
|
| Survival Rate | 7 | 2015 | 795 | 0.550 |
Why?
|
| Nerve Block | 2 | 2015 | 48 | 0.530 |
Why?
|
| Aortic Rupture | 4 | 2011 | 7 | 0.530 |
Why?
|
| Lower Extremity | 2 | 2014 | 93 | 0.530 |
Why?
|
| Medicare | 3 | 2015 | 185 | 0.530 |
Why?
|
| Anesthetics, Local | 2 | 2015 | 77 | 0.530 |
Why?
|
| Diffusion of Innovation | 1 | 2015 | 29 | 0.520 |
Why?
|
| Catheters, Indwelling | 1 | 2015 | 40 | 0.520 |
Why?
|
| Botulinum Toxins | 2 | 2012 | 37 | 0.510 |
Why?
|
| Subclavian Steal Syndrome | 2 | 2013 | 5 | 0.500 |
Why?
|
| Chi-Square Distribution | 11 | 2015 | 292 | 0.500 |
Why?
|
| Aged, 80 and over | 11 | 2015 | 3712 | 0.500 |
Why?
|
| Mother-Child Relations | 1 | 2014 | 15 | 0.500 |
Why?
|
| Interprofessional Relations | 2 | 2011 | 47 | 0.500 |
Why?
|
| Constriction, Pathologic | 4 | 2016 | 41 | 0.490 |
Why?
|
| Hospitals, Rural | 2 | 2011 | 10 | 0.490 |
Why?
|
| Incidence | 11 | 2015 | 1105 | 0.490 |
Why?
|
| Physician Self-Referral | 1 | 2014 | 3 | 0.490 |
Why?
|
| Critical Care | 1 | 2015 | 114 | 0.480 |
Why?
|
| Patient-Centered Care | 1 | 2014 | 68 | 0.480 |
Why?
|
| Angioplasty | 5 | 2014 | 31 | 0.480 |
Why?
|
| Biomedical Research | 2 | 2015 | 153 | 0.470 |
Why?
|
| Kidney Failure, Chronic | 2 | 2015 | 518 | 0.470 |
Why?
|
| Hospital Costs | 5 | 2014 | 36 | 0.460 |
Why?
|
| Prospective Studies | 8 | 2015 | 2010 | 0.460 |
Why?
|
| Thrombophilia | 1 | 2013 | 6 | 0.450 |
Why?
|
| Child | 7 | 2015 | 2209 | 0.450 |
Why?
|
| Ischemia | 6 | 2015 | 92 | 0.450 |
Why?
|
| Upper Extremity | 1 | 2013 | 52 | 0.440 |
Why?
|
| Predictive Value of Tests | 8 | 2016 | 784 | 0.430 |
Why?
|
| Education, Medical, Continuing | 3 | 2010 | 45 | 0.420 |
Why?
|
| Duodenal Diseases | 1 | 2011 | 2 | 0.420 |
Why?
|
| Interinstitutional Relations | 1 | 2011 | 11 | 0.410 |
Why?
|
| Health Care Sector | 1 | 2011 | 18 | 0.410 |
Why?
|
| Intestinal Fistula | 1 | 2011 | 11 | 0.410 |
Why?
|
| Education, Premedical | 1 | 2011 | 2 | 0.410 |
Why?
|
| Medical Staff Privileges | 1 | 2011 | 1 | 0.410 |
Why?
|
| Emergency Service, Hospital | 3 | 2014 | 429 | 0.410 |
Why?
|
| Credentialing | 1 | 2011 | 8 | 0.410 |
Why?
|
| Organizational Culture | 4 | 2013 | 26 | 0.410 |
Why?
|
| Age Factors | 7 | 2015 | 1105 | 0.400 |
Why?
|
| Multivariate Analysis | 14 | 2014 | 636 | 0.400 |
Why?
|
| Students, Medical | 5 | 2014 | 121 | 0.400 |
Why?
|
| Splenic Artery | 1 | 2011 | 12 | 0.400 |
Why?
|
| Aneurysm, False | 1 | 2011 | 13 | 0.400 |
Why?
|
| Marriage | 1 | 2010 | 4 | 0.390 |
Why?
|
| Patient Transfer | 1 | 2011 | 34 | 0.390 |
Why?
|
| Liability, Legal | 2 | 2013 | 28 | 0.380 |
Why?
|
| Reoperation | 4 | 2014 | 203 | 0.380 |
Why?
|
| Cross-Sectional Studies | 7 | 2015 | 1353 | 0.380 |
Why?
|
| Safety Management | 3 | 2013 | 31 | 0.380 |
Why?
|
| Secondary Prevention | 1 | 2010 | 59 | 0.380 |
Why?
|
| Operating Rooms | 5 | 2010 | 32 | 0.370 |
Why?
|
| Embolization, Therapeutic | 1 | 2011 | 79 | 0.370 |
Why?
|
| Colonic Diseases | 1 | 2010 | 5 | 0.370 |
Why?
|
| Neurotoxins | 1 | 2010 | 16 | 0.370 |
Why?
|
| Muscle Denervation | 1 | 2010 | 28 | 0.370 |
Why?
|
| Diagnosis, Differential | 5 | 2014 | 493 | 0.360 |
Why?
|
| Students | 1 | 2011 | 167 | 0.360 |
Why?
|
| Blood Vessel Prosthesis | 4 | 2014 | 78 | 0.360 |
Why?
|
| Perioperative Care | 3 | 2007 | 58 | 0.360 |
Why?
|
| Radiography | 4 | 2014 | 353 | 0.350 |
Why?
|
| Health Care Costs | 3 | 2016 | 108 | 0.350 |
Why?
|
| Magnetic Resonance Angiography | 3 | 2010 | 64 | 0.350 |
Why?
|
| Hospitalization | 3 | 2012 | 417 | 0.350 |
Why?
|
| Parenting | 1 | 2009 | 18 | 0.340 |
Why?
|
| Aneurysm, Ruptured | 1 | 2009 | 26 | 0.340 |
Why?
|
| Logistic Models | 9 | 2015 | 725 | 0.340 |
Why?
|
| Research Design | 3 | 2016 | 285 | 0.340 |
Why?
|
| Urology | 1 | 2009 | 30 | 0.330 |
Why?
|
| Clinical Trials as Topic | 1 | 2010 | 298 | 0.330 |
Why?
|
| Muscle, Skeletal | 2 | 2010 | 494 | 0.330 |
Why?
|
| Communication | 1 | 2009 | 122 | 0.330 |
Why?
|
| Prejudice | 4 | 2014 | 45 | 0.330 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2010 | 462 | 0.320 |
Why?
|
| Brachiocephalic Trunk | 1 | 2007 | 5 | 0.310 |
Why?
|
| Orthopedic Procedures | 1 | 2009 | 92 | 0.310 |
Why?
|
| Health Planning | 1 | 2007 | 5 | 0.300 |
Why?
|
| Hospitals, Special | 1 | 2007 | 5 | 0.300 |
Why?
|
| Specimen Handling | 1 | 2007 | 31 | 0.300 |
Why?
|
| Bandages | 1 | 2006 | 33 | 0.290 |
Why?
|
| Needlestick Injuries | 1 | 2006 | 1 | 0.290 |
Why?
|
| Wounds, Stab | 1 | 2006 | 3 | 0.290 |
Why?
|
| Aorta, Abdominal | 2 | 2019 | 26 | 0.290 |
Why?
|
| Accidents, Occupational | 1 | 2006 | 15 | 0.290 |
Why?
|
| Health Services Needs and Demand | 1 | 2007 | 66 | 0.290 |
Why?
|
| Terminology as Topic | 2 | 2016 | 62 | 0.280 |
Why?
|
| Cohort Studies | 6 | 2013 | 1674 | 0.280 |
Why?
|
| Depression | 3 | 2018 | 378 | 0.280 |
Why?
|
| Comorbidity | 6 | 2014 | 539 | 0.280 |
Why?
|
| Burns | 1 | 2006 | 97 | 0.270 |
Why?
|
| Odds Ratio | 7 | 2014 | 446 | 0.270 |
Why?
|
| Databases, Factual | 6 | 2018 | 331 | 0.260 |
Why?
|
| Chronic Disease | 4 | 2011 | 369 | 0.260 |
Why?
|
| Blood Transfusion, Autologous | 1 | 2004 | 3 | 0.250 |
Why?
|
| Prosthesis Design | 3 | 2014 | 87 | 0.250 |
Why?
|
| Intraoperative Care | 1 | 2004 | 48 | 0.250 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2015 | 82 | 0.240 |
Why?
|
| Stereotyping | 2 | 2017 | 6 | 0.240 |
Why?
|
| Lymphokines | 1 | 2003 | 10 | 0.240 |
Why?
|
| Endothelial Growth Factors | 1 | 2003 | 12 | 0.240 |
Why?
|
| Injections | 2 | 2015 | 61 | 0.240 |
Why?
|
| Sex Factors | 10 | 2017 | 626 | 0.230 |
Why?
|
| Cell Division | 1 | 2003 | 97 | 0.230 |
Why?
|
| Aortic Aneurysm, Thoracic | 2 | 2013 | 11 | 0.230 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2003 | 71 | 0.230 |
Why?
|
| Quality Indicators, Health Care | 2 | 2013 | 55 | 0.230 |
Why?
|
| Axillary Artery | 1 | 2002 | 1 | 0.230 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2003 | 100 | 0.220 |
Why?
|
| Decision Support Techniques | 2 | 2014 | 104 | 0.220 |
Why?
|
| European Continental Ancestry Group | 6 | 2015 | 1131 | 0.220 |
Why?
|
| Linear Models | 5 | 2014 | 425 | 0.210 |
Why?
|
| Family Conflict | 2 | 2012 | 6 | 0.210 |
Why?
|
| Internet | 9 | 2013 | 156 | 0.210 |
Why?
|
| Population Surveillance | 3 | 2012 | 119 | 0.210 |
Why?
|
| Reproducibility of Results | 4 | 2014 | 724 | 0.210 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2014 | 40 | 0.210 |
Why?
|
| Patient Satisfaction | 2 | 2013 | 222 | 0.200 |
Why?
|
| Ultrasonography, Doppler, Color | 2 | 2013 | 17 | 0.200 |
Why?
|
| Warfarin | 2 | 2014 | 30 | 0.200 |
Why?
|
| Fibrinolytic Agents | 2 | 2014 | 70 | 0.200 |
Why?
|
| Recovery of Function | 2 | 2015 | 190 | 0.200 |
Why?
|
| Analgesics, Opioid | 2 | 2015 | 236 | 0.200 |
Why?
|
| Morbidity | 3 | 2010 | 91 | 0.190 |
Why?
|
| Hospitals, Veterans | 2 | 2010 | 33 | 0.190 |
Why?
|
| Carotid Artery Diseases | 3 | 2012 | 109 | 0.190 |
Why?
|
| Ischemic Attack, Transient | 2 | 2014 | 46 | 0.190 |
Why?
|
| Schools, Medical | 2 | 2018 | 42 | 0.190 |
Why?
|
| Prevalence | 4 | 2011 | 892 | 0.180 |
Why?
|
| Cause of Death | 4 | 2019 | 219 | 0.180 |
Why?
|
| Pain Measurement | 2 | 2012 | 360 | 0.180 |
Why?
|
| Personnel Selection | 2 | 2017 | 14 | 0.180 |
Why?
|
| Prognosis | 4 | 2016 | 1362 | 0.180 |
Why?
|
| Data Collection | 4 | 2015 | 163 | 0.180 |
Why?
|
| Hospital Charges | 2 | 2010 | 13 | 0.180 |
Why?
|
| Cultural Diversity | 2 | 2017 | 19 | 0.170 |
Why?
|
| California | 3 | 2015 | 60 | 0.170 |
Why?
|
| Lasers | 3 | 2008 | 19 | 0.170 |
Why?
|
| Personnel Staffing and Scheduling | 2 | 2010 | 18 | 0.170 |
Why?
|
| Amputation | 3 | 2015 | 37 | 0.170 |
Why?
|
| Angiography | 3 | 2016 | 75 | 0.170 |
Why?
|
| Financial Support | 1 | 2018 | 6 | 0.170 |
Why?
|
| Family | 2 | 2017 | 105 | 0.170 |
Why?
|
| Pain | 2 | 2012 | 282 | 0.170 |
Why?
|
| Faculty | 1 | 2018 | 15 | 0.170 |
Why?
|
| Industry | 1 | 2018 | 15 | 0.170 |
Why?
|
| Cooperative Behavior | 2 | 2011 | 73 | 0.170 |
Why?
|
| Maryland | 2 | 2015 | 26 | 0.160 |
Why?
|
| Feeding Behavior | 1 | 2019 | 159 | 0.160 |
Why?
|
| Quality Assurance, Health Care | 3 | 2007 | 61 | 0.160 |
Why?
|
| Fellowships and Scholarships | 3 | 2015 | 50 | 0.160 |
Why?
|
| Emergencies | 3 | 2014 | 45 | 0.160 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2010 | 871 | 0.160 |
Why?
|
| Spectrometry, Fluorescence | 2 | 2008 | 24 | 0.150 |
Why?
|
| Specialization | 1 | 2017 | 30 | 0.150 |
Why?
|
| Interpersonal Relations | 1 | 2017 | 54 | 0.150 |
Why?
|
| Interdisciplinary Communication | 2 | 2006 | 53 | 0.140 |
Why?
|
| Smoking | 2 | 2014 | 427 | 0.140 |
Why?
|
| Obesity | 2 | 2013 | 1062 | 0.140 |
Why?
|
| Planning Techniques | 1 | 2015 | 1 | 0.130 |
Why?
|
| Ticlopidine | 1 | 2015 | 17 | 0.130 |
Why?
|
| Nurses | 1 | 2015 | 14 | 0.130 |
Why?
|
| Conflict of Interest | 2 | 2013 | 39 | 0.130 |
Why?
|
| History, 19th Century | 1 | 2014 | 17 | 0.130 |
Why?
|
| Thoracotomy | 1 | 2014 | 22 | 0.130 |
Why?
|
| Aspirin | 1 | 2015 | 61 | 0.130 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2007 | 126 | 0.130 |
Why?
|
| Hospitals | 1 | 2015 | 89 | 0.130 |
Why?
|
| Traumatology | 1 | 2014 | 14 | 0.130 |
Why?
|
| History, 21st Century | 1 | 2014 | 48 | 0.130 |
Why?
|
| United States Department of Veterans Affairs | 2 | 2014 | 49 | 0.130 |
Why?
|
| Outpatients | 1 | 2014 | 49 | 0.130 |
Why?
|
| Hispanic Americans | 4 | 2015 | 904 | 0.130 |
Why?
|
| History, 20th Century | 1 | 2014 | 68 | 0.130 |
Why?
|
| Radiography, Thoracic | 1 | 2014 | 43 | 0.130 |
Why?
|
| Diabetic Foot | 1 | 2014 | 19 | 0.120 |
Why?
|
| Health Expenditures | 1 | 2014 | 61 | 0.120 |
Why?
|
| Patient Admission | 1 | 2014 | 53 | 0.120 |
Why?
|
| Cost-Benefit Analysis | 3 | 2016 | 159 | 0.120 |
Why?
|
| Edema | 1 | 2013 | 30 | 0.120 |
Why?
|
| Inpatients | 1 | 2014 | 64 | 0.120 |
Why?
|
| Consent Forms | 1 | 2013 | 8 | 0.120 |
Why?
|
| Congresses as Topic | 2 | 2018 | 37 | 0.120 |
Why?
|
| Alcoholism | 2 | 2012 | 95 | 0.120 |
Why?
|
| Veins | 1 | 2013 | 29 | 0.120 |
Why?
|
| Jurisprudence | 1 | 2013 | 7 | 0.120 |
Why?
|
| Injections, Intramuscular | 2 | 2010 | 42 | 0.120 |
Why?
|
| Malpractice | 1 | 2013 | 20 | 0.110 |
Why?
|
| Hemodynamics | 1 | 2013 | 148 | 0.110 |
Why?
|
| Work Schedule Tolerance | 2 | 2012 | 9 | 0.110 |
Why?
|
| Proportional Hazards Models | 5 | 2015 | 706 | 0.110 |
Why?
|
| Archives | 1 | 2012 | 1 | 0.110 |
Why?
|
| Survival Analysis | 2 | 2012 | 440 | 0.110 |
Why?
|
| American Medical Association | 1 | 2012 | 6 | 0.110 |
Why?
|
| Sensitivity and Specificity | 3 | 2008 | 531 | 0.110 |
Why?
|
| Life Style | 2 | 2012 | 363 | 0.110 |
Why?
|
| Hernia | 1 | 2012 | 12 | 0.110 |
Why?
|
| Leg | 2 | 2002 | 56 | 0.110 |
Why?
|
| Photochemotherapy | 2 | 2002 | 16 | 0.110 |
Why?
|
| Tunica Intima | 2 | 2002 | 59 | 0.110 |
Why?
|
| Photosensitizing Agents | 2 | 2002 | 19 | 0.110 |
Why?
|
| Health Services Accessibility | 1 | 2014 | 231 | 0.110 |
Why?
|
| International Classification of Diseases | 1 | 2012 | 26 | 0.110 |
Why?
|
| Endarterectomy | 1 | 2012 | 7 | 0.110 |
Why?
|
| Treatment Failure | 1 | 2012 | 159 | 0.110 |
Why?
|
| Axilla | 1 | 2011 | 15 | 0.110 |
Why?
|
| Health Care Surveys | 1 | 2012 | 176 | 0.100 |
Why?
|
| Private Sector | 1 | 2011 | 8 | 0.100 |
Why?
|
| Codes of Ethics | 1 | 2011 | 2 | 0.100 |
Why?
|
| Mental Health | 1 | 2012 | 102 | 0.100 |
Why?
|
| Scientific Misconduct | 1 | 2011 | 4 | 0.100 |
Why?
|
| Peritonitis | 1 | 2011 | 10 | 0.100 |
Why?
|
| Endoscopy, Digestive System | 1 | 2011 | 9 | 0.100 |
Why?
|
| Catheterization | 1 | 2011 | 58 | 0.100 |
Why?
|
| Efficiency, Organizational | 2 | 2008 | 18 | 0.100 |
Why?
|
| Joint Commission on Accreditation of Healthcare Organizations | 1 | 2011 | 3 | 0.100 |
Why?
|
| Public Opinion | 1 | 2011 | 17 | 0.100 |
Why?
|
| Guidelines as Topic | 1 | 2011 | 45 | 0.100 |
Why?
|
| Trust | 1 | 2011 | 39 | 0.100 |
Why?
|
| Confidentiality | 1 | 2011 | 22 | 0.100 |
Why?
|
| Pancreatitis, Chronic | 1 | 2011 | 8 | 0.100 |
Why?
|
| Thrombectomy | 1 | 2011 | 58 | 0.100 |
Why?
|
| Feasibility Studies | 3 | 2008 | 262 | 0.100 |
Why?
|
| Iliac Artery | 3 | 2013 | 46 | 0.100 |
Why?
|
| Patient Readmission | 1 | 2012 | 105 | 0.100 |
Why?
|
| Angiography, Digital Subtraction | 2 | 2012 | 18 | 0.100 |
Why?
|
| Abdominal Pain | 1 | 2011 | 40 | 0.100 |
Why?
|
| Job Description | 1 | 2010 | 3 | 0.100 |
Why?
|
| Night Care | 1 | 2010 | 1 | 0.100 |
Why?
|
| Health Planning Guidelines | 1 | 2010 | 5 | 0.100 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2010 | 12 | 0.100 |
Why?
|
| Esophageal Fistula | 1 | 2010 | 9 | 0.100 |
Why?
|
| After-Hours Care | 1 | 2010 | 6 | 0.100 |
Why?
|
| Vascular Fistula | 1 | 2010 | 5 | 0.100 |
Why?
|
| Family Characteristics | 1 | 2010 | 32 | 0.100 |
Why?
|
| Depersonalization | 1 | 2010 | 3 | 0.100 |
Why?
|
| Checklist | 1 | 2010 | 35 | 0.090 |
Why?
|
| Pain, Postoperative | 1 | 2012 | 173 | 0.090 |
Why?
|
| Multicenter Studies as Topic | 1 | 2010 | 92 | 0.090 |
Why?
|
| Sex Distribution | 1 | 2010 | 185 | 0.090 |
Why?
|
| Program Development | 1 | 2010 | 85 | 0.090 |
Why?
|
| Scleroderma, Localized | 1 | 2010 | 5 | 0.090 |
Why?
|
| Colectomy | 1 | 2010 | 25 | 0.090 |
Why?
|
| African Continental Ancestry Group | 1 | 2011 | 350 | 0.090 |
Why?
|
| Colonic Neoplasms | 1 | 2010 | 63 | 0.090 |
Why?
|
| Atherosclerosis | 2 | 2006 | 691 | 0.090 |
Why?
|
| Catheterization, Peripheral | 1 | 2009 | 24 | 0.090 |
Why?
|
| African Americans | 5 | 2015 | 1373 | 0.090 |
Why?
|
| Delegation, Professional | 1 | 2009 | 1 | 0.090 |
Why?
|
| Personnel Delegation | 1 | 2009 | 1 | 0.090 |
Why?
|
| Animals | 6 | 2014 | 7297 | 0.090 |
Why?
|
| Spouses | 1 | 2009 | 8 | 0.090 |
Why?
|
| Sick Leave | 1 | 2009 | 4 | 0.090 |
Why?
|
| Efficiency | 1 | 2009 | 16 | 0.090 |
Why?
|
| Combined Modality Therapy | 1 | 2010 | 524 | 0.080 |
Why?
|
| Organizational Innovation | 1 | 2009 | 30 | 0.080 |
Why?
|
| Fiber Optic Technology | 1 | 2008 | 14 | 0.080 |
Why?
|
| Total Quality Management | 1 | 2008 | 19 | 0.080 |
Why?
|
| Patient Care Management | 1 | 2008 | 17 | 0.080 |
Why?
|
| Patient Care | 1 | 2008 | 33 | 0.080 |
Why?
|
| Carotid Artery, Common | 1 | 2008 | 37 | 0.080 |
Why?
|
| Tendons | 1 | 2008 | 57 | 0.080 |
Why?
|
| Continuity of Patient Care | 1 | 2008 | 64 | 0.080 |
Why?
|
| Longitudinal Studies | 1 | 2010 | 708 | 0.080 |
Why?
|
| Disability Evaluation | 1 | 2009 | 210 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2015 | 1007 | 0.080 |
Why?
|
| Hematoma | 1 | 2007 | 23 | 0.080 |
Why?
|
| Patient Identification Systems | 1 | 2007 | 1 | 0.080 |
Why?
|
| Blood Sedimentation | 1 | 2007 | 5 | 0.080 |
Why?
|
| Postoperative Hemorrhage | 1 | 2007 | 38 | 0.080 |
Why?
|
| Education, Medical | 2 | 2005 | 67 | 0.080 |
Why?
|
| Diuretics | 1 | 2007 | 22 | 0.080 |
Why?
|
| Brachial Plexus | 1 | 2007 | 26 | 0.070 |
Why?
|
| Polyurethanes | 1 | 2006 | 4 | 0.070 |
Why?
|
| Permeability | 1 | 2006 | 9 | 0.070 |
Why?
|
| Blood-Borne Pathogens | 1 | 2006 | 7 | 0.070 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2006 | 11 | 0.070 |
Why?
|
| Mortality | 1 | 2007 | 108 | 0.070 |
Why?
|
| Aorta | 2 | 2004 | 103 | 0.070 |
Why?
|
| Consensus | 2 | 2016 | 68 | 0.070 |
Why?
|
| Physician-Nurse Relations | 1 | 2006 | 4 | 0.070 |
Why?
|
| Nursing Staff, Hospital | 1 | 2006 | 10 | 0.070 |
Why?
|
| Risk Management | 1 | 2006 | 29 | 0.070 |
Why?
|
| Medical Staff, Hospital | 1 | 2006 | 18 | 0.070 |
Why?
|
| Los Angeles | 2 | 2002 | 8 | 0.070 |
Why?
|
| Para-Aortic Bodies | 1 | 2006 | 1 | 0.070 |
Why?
|
| Paraganglioma | 1 | 2006 | 5 | 0.070 |
Why?
|
| Polytetrafluoroethylene | 2 | 2002 | 12 | 0.070 |
Why?
|
| Patient Discharge | 1 | 2007 | 168 | 0.070 |
Why?
|
| Philosophy, Medical | 1 | 2005 | 1 | 0.070 |
Why?
|
| Preoperative Care | 1 | 2007 | 110 | 0.070 |
Why?
|
| Safety | 1 | 2006 | 72 | 0.070 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2006 | 20 | 0.070 |
Why?
|
| Pregnancy | 1 | 2009 | 807 | 0.070 |
Why?
|
| Laparotomy | 1 | 2006 | 32 | 0.070 |
Why?
|
| Axillary Vein | 1 | 2005 | 1 | 0.070 |
Why?
|
| Research Support as Topic | 2 | 2016 | 25 | 0.070 |
Why?
|
| Hyperplasia | 2 | 2002 | 38 | 0.070 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2006 | 46 | 0.070 |
Why?
|
| Propensity Score | 2 | 2015 | 34 | 0.070 |
Why?
|
| Wound Healing | 1 | 2006 | 182 | 0.070 |
Why?
|
| Microscopy, Fluorescence | 1 | 2005 | 81 | 0.070 |
Why?
|
| Needs Assessment | 1 | 2005 | 66 | 0.070 |
Why?
|
| Quality-Adjusted Life Years | 2 | 2016 | 23 | 0.060 |
Why?
|
| Cognition | 1 | 2009 | 524 | 0.060 |
Why?
|
| Blood Preservation | 1 | 2004 | 9 | 0.060 |
Why?
|
| Mitogens | 1 | 2003 | 2 | 0.060 |
Why?
|
| Bromodeoxyuridine | 1 | 2003 | 6 | 0.060 |
Why?
|
| Retinoblastoma Protein | 1 | 2003 | 10 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2003 | 12 | 0.060 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2004 | 35 | 0.060 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2003 | 13 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2003 | 37 | 0.060 |
Why?
|
| Drug Therapy, Combination | 2 | 2015 | 273 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2003 | 44 | 0.060 |
Why?
|
| Professional Practice | 1 | 2003 | 23 | 0.060 |
Why?
|
| Surgical Wound Infection | 1 | 2004 | 74 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2003 | 37 | 0.060 |
Why?
|
| Macrophages | 1 | 2005 | 188 | 0.060 |
Why?
|
| Infant | 1 | 2006 | 967 | 0.060 |
Why?
|
| Inflammation | 1 | 2007 | 503 | 0.060 |
Why?
|
| Kinetics | 1 | 2003 | 205 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2003 | 102 | 0.060 |
Why?
|
| Phosphorylation | 1 | 2003 | 225 | 0.060 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 248 | 0.060 |
Why?
|
| Child, Preschool | 1 | 2006 | 1164 | 0.060 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2002 | 8 | 0.060 |
Why?
|
| Cell Survival | 1 | 2003 | 272 | 0.060 |
Why?
|
| Organometallic Compounds | 1 | 2002 | 18 | 0.050 |
Why?
|
| Jugular Veins | 1 | 2002 | 26 | 0.050 |
Why?
|
| Cellophane | 1 | 2002 | 1 | 0.050 |
Why?
|
| Smoke | 1 | 2002 | 12 | 0.050 |
Why?
|
| Pancreatitis | 1 | 2002 | 18 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 641 | 0.050 |
Why?
|
| Drug Delivery Systems | 1 | 2002 | 92 | 0.050 |
Why?
|
| Cells, Cultured | 1 | 2003 | 799 | 0.050 |
Why?
|
| Pancreas | 1 | 2002 | 79 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2007 | 1218 | 0.050 |
Why?
|
| Rabbits | 3 | 2006 | 185 | 0.050 |
Why?
|
| Limb Salvage | 2 | 2014 | 24 | 0.040 |
Why?
|
| Disease Models, Animal | 4 | 2005 | 980 | 0.040 |
Why?
|
| Disclosure | 1 | 2018 | 36 | 0.040 |
Why?
|
| Inservice Training | 1 | 2017 | 11 | 0.040 |
Why?
|
| Awareness | 1 | 2017 | 28 | 0.040 |
Why?
|
| Health Services Research | 1 | 2017 | 78 | 0.040 |
Why?
|
| Teaching | 1 | 2017 | 55 | 0.040 |
Why?
|
| Health Resources | 1 | 2016 | 33 | 0.040 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2016 | 28 | 0.040 |
Why?
|
| Diagnostic Imaging | 1 | 2016 | 88 | 0.030 |
Why?
|
| Risk Adjustment | 1 | 2015 | 27 | 0.030 |
Why?
|
| Platelet Function Tests | 1 | 2015 | 6 | 0.030 |
Why?
|
| Association | 1 | 2015 | 6 | 0.030 |
Why?
|
| Peer Review, Research | 1 | 2015 | 6 | 0.030 |
Why?
|
| Psychological Tests | 1 | 2015 | 33 | 0.030 |
Why?
|
| Medically Uninsured | 1 | 2015 | 31 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2006 | 454 | 0.030 |
Why?
|
| Point-of-Care Systems | 1 | 2015 | 33 | 0.030 |
Why?
|
| Medicaid | 1 | 2015 | 83 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2015 | 175 | 0.030 |
Why?
|
| Critical Illness | 1 | 2015 | 87 | 0.030 |
Why?
|
| Bradycardia | 1 | 2013 | 15 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 325 | 0.030 |
Why?
|
| Authorship | 1 | 2013 | 8 | 0.030 |
Why?
|
| Plagiarism | 1 | 2013 | 4 | 0.030 |
Why?
|
| Journal Impact Factor | 1 | 2013 | 9 | 0.030 |
Why?
|
| Brain Damage, Chronic | 1 | 2013 | 3 | 0.030 |
Why?
|
| Hypotension | 1 | 2013 | 47 | 0.030 |
Why?
|
| Hair Removal | 1 | 2013 | 5 | 0.030 |
Why?
|
| Quadriplegia | 1 | 2013 | 11 | 0.030 |
Why?
|
| Urinary Catheterization | 1 | 2013 | 14 | 0.030 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2013 | 29 | 0.030 |
Why?
|
| Least-Squares Analysis | 1 | 2012 | 29 | 0.030 |
Why?
|
| Device Removal | 1 | 2013 | 31 | 0.030 |
Why?
|
| Life Change Events | 1 | 2012 | 21 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2013 | 249 | 0.030 |
Why?
|
| Anesthesia | 1 | 2013 | 65 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2013 | 272 | 0.030 |
Why?
|
| Popliteal Artery | 1 | 2012 | 6 | 0.030 |
Why?
|
| Dogs | 2 | 2002 | 117 | 0.030 |
Why?
|
| Insurance, Health | 1 | 2013 | 91 | 0.030 |
Why?
|
| Risk Reduction Behavior | 1 | 2012 | 115 | 0.030 |
Why?
|
| Heart Rate | 1 | 2013 | 315 | 0.030 |
Why?
|
| Disease Progression | 1 | 2014 | 572 | 0.030 |
Why?
|
| Economic Competition | 1 | 2010 | 9 | 0.020 |
Why?
|
| Appendectomy | 1 | 2010 | 15 | 0.020 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2010 | 20 | 0.020 |
Why?
|
| Bariatric Surgery | 1 | 2010 | 16 | 0.020 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2010 | 12 | 0.020 |
Why?
|
| Aortography | 1 | 2010 | 16 | 0.020 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2010 | 18 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2010 | 78 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 863 | 0.020 |
Why?
|
| Ethnic Groups | 1 | 2013 | 440 | 0.020 |
Why?
|
| Prostatectomy | 1 | 2010 | 79 | 0.020 |
Why?
|
| Erectile Dysfunction | 1 | 2009 | 48 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2012 | 862 | 0.020 |
Why?
|
| Foam Cells | 1 | 2008 | 11 | 0.020 |
Why?
|
| Elastin | 1 | 2008 | 14 | 0.020 |
Why?
|
| Rupture | 1 | 2008 | 29 | 0.020 |
Why?
|
| Necrosis | 1 | 2008 | 53 | 0.020 |
Why?
|
| Fibrosis | 1 | 2008 | 102 | 0.020 |
Why?
|
| Calcinosis | 1 | 2008 | 143 | 0.020 |
Why?
|
| Collagen | 1 | 2008 | 217 | 0.020 |
Why?
|
| Lipids | 1 | 2008 | 208 | 0.020 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2006 | 10 | 0.020 |
Why?
|
| ROC Curve | 1 | 2007 | 148 | 0.020 |
Why?
|
| Nurse's Role | 1 | 2006 | 7 | 0.020 |
Why?
|
| Carotid Body Tumor | 1 | 2006 | 3 | 0.020 |
Why?
|
| Child Care | 1 | 2005 | 10 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2005 | 129 | 0.020 |
Why?
|
| Clinical Clerkship | 1 | 2005 | 41 | 0.020 |
Why?
|
| Staff Development | 1 | 2005 | 13 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2007 | 855 | 0.020 |
Why?
|
| Carotid Artery, Internal | 1 | 2004 | 29 | 0.010 |
Why?
|
| Curriculum | 1 | 2005 | 196 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2005 | 241 | 0.010 |
Why?
|
| Boston | 1 | 2002 | 16 | 0.010 |
Why?
|
| Tibial Arteries | 1 | 2002 | 1 | 0.010 |
Why?
|
| Cell Count | 1 | 2002 | 50 | 0.010 |
Why?
|
| Brain Ischemia | 1 | 2004 | 136 | 0.010 |
Why?
|
| Radiometry | 1 | 2002 | 39 | 0.010 |
Why?
|
| Anesthesia, General | 1 | 2002 | 29 | 0.010 |
Why?
|
| Anesthesia, Conduction | 1 | 2002 | 29 | 0.010 |
Why?
|
| Mesocricetus | 1 | 2002 | 3 | 0.010 |
Why?
|
| Attitude to Health | 1 | 2003 | 147 | 0.010 |
Why?
|
| Cricetinae | 1 | 2002 | 58 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2002 | 281 | 0.010 |
Why?
|
| Risk | 1 | 2002 | 289 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2002 | 345 | 0.010 |
Why?
|